CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/dermatomyositis.
Wong
Richard C W
RC
Klingberg
Sandra
S
Wilson
Robert
R
D000951:Antigens, Neoplasm / Q000097:blood; D001681:Biological Assay / Q000379:methods*; D015415:Biomarkers / Q000097:blood; D001707:Biopsy, Needle; D003882:Dermatomyositis / Q000150:complications / Q000175:diagnosis*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000175:diagnosis*; D018396:Mucin-1 / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D017285:Polymyositis / Q000150:complications / Q000175:diagnosis*; D011347:Procollagen / Q000097:blood*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D000951:Antigens, Neoplasm; D015415:Biomarkers; D018396:Mucin-1; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide